Full Press Release Details
General Meeting of Shareholders
of Intercure Ltd. held on December 30, 2021
to National Instrument 51-102 Continuous Disclosure Obligations Section 11.3
ISRAEL - (December 30, 2021) Intercure Ltd. (the "Company") announces today the results of the Annual General
Meeting of shareholders of the Company, held today, Thursday, December 30, 2021, in Bnei Brak, Israel (the "Meeting").
At the Meeting, all of the proposals set forth in the Company's management information circular dated November 29, 2021 (the "Circular")
were approved by the required majority of the shareholders. The resolutions were as follows:
1: Election of Lennie Michelson Grinbaum
Michelson Grinbaum was elected to hold office as an external director of Intercure, commencing on September 4, 2021 for a period of three
years. Based on proxies received prior to the Meeting, votes were cast as follows:
| FOR | Voters who voted FOR and are not a controlling shareholder / have a personal interest | AGAINST | WITHHELD | |||||||||||||
| Vote | 14,631,775 | 4,805,372 | 327,975 | 1,042 | ||||||||||||
| % of all votes | 97.80 | % | 32.12 | % | 2.19 | % | 0.007 | % | ||||||||
| % of all votes out of non controlling shareholders / those who have a personal interest - not including withheld | 93.61 | % | 6.38 | % |
2: Election of Gideon Hirschfeld
Hirschfeld was elected to hold office as an external director of Intercure, commencing on September 24, 2021 for a period of three years.
Based on proxies received prior to the Meeting, votes were cast as follows:
| FOR | Voters Who Voted FOR and Are Not a Controlling Shareholder / Have a Personal Interest | AGAINST | WITHHELD | |||||||||||||
| Vote | 14,626,287 | 4,800,897 | 328,049 | 456 | ||||||||||||
| % of all votes | 97.81 | % | 32.10 | % | 2.19 | % | 0.003 | % | ||||||||
| % of all votes out of non controlling shareholders / those who have a personal interest - not including withheld | 93.6 | % | 6.39 | % |
Circular contains a full description of the matters voted upon at the Meeting, a copy of which is available at www.sedar.com.
InterCure (dba Canndoc)
(dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North
America. Canndoc, a wholly owned subsidiary of InterCure, is Israel's largest licensed cannabis producer and one of the first to
offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market
leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale"
model to lead the fastest growing cannabis global market outside of North America.
more information, visit: http://www.intercure.co.
further information, please contact:
Cohen, Chief Financial Officer